Watkins Tim's Form 4 filing
Contineum Therapeutics, Inc. (CTNM) · filed Jan 30, 2026
- Accession no.
- 0001437749-26-002575
- Filed
- Jan 30, 2026
- Trade date
- Jan 28-30, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $51.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Watkins TimCIK 0002065965 | Officer (CMO & Head of Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | Class A Common Stock | MOption exerciseAcquired | +3,611 | $4.50 | +$16,249.5 | 3,611 | Direct | |
| Jan 28, 2026 | Class A Common Stock | SSaleDisposed | −2,800 | $14.09 | −$39,452 | 811 | Direct | |
| Jan 28, 2026 | Class A Common Stock | SSaleDisposed | −811 | $14.48 | −$11,743.28 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | Class A Common Stock | MOption exerciseDisposed | −3,611 | $0.00 | $0 | 252,778 | Direct | |
| Jan 30, 2026 | Class A Common Stock | AGrant or awardAcquired | +160,000 | $0.00 | $0 | 160,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.